Protective effect of transforming growth factor-β1 on β-amyloid neurotoxicity in rat hippocampal neurons

Molecular Pharmacology

Volumn 49, Issue 2, 1996, Pages 319-328

  Prehn, Jochen H M ^a,c   Bindokas, Vytautas P ^a   Jordán, Joaquín ^a   Galindo, María F ^a   Ghadge, Ghanashyam D ^a   Roos, Raymond P ^a   Boise, Lawrence H ^a   Thompson, Craig B ^a   Krajewski, Stanislaw ^b   Reed, John C ^b   Miller, Richard J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BURNHAM INSTITUTE   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN PROTECTION; CELL VIABILITY; HIPPOCAMPUS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 9044243405     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Kang, J., H.-G. Lemaire, A. Unterbeck, J. M. Salbaum, C. L. Masters, K.-H. Grzeschik, G. Multhaup, K. Beyreuther, and B. Muller-Hill. The precursors of Alzheimer's disease: amyloid A4 protein resembles a cell-surface receptor. Nature (Lond.) 325:733-736 (1987).
2. Selkoe, D. J. The molecular pathology of Alzheimer's disease. Neuron 6:487-498 (1991).
3. Glenner, G. G. Alzheimer's disease: its proteins and genes. Cell 52:307-308 (1988).
4. Yankner, B. A., L. K. Duffy, and D. A. Kirschner. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science (Washington D.) 250:279-282 (1990).
5. Frautschy, S A., A. Baird, and G. M. Cole. Effects of injected Alzheimer β-amyloid cores in rat brain. Proc. Natl. Acad. Sci. USA 88:8362-8366 (1991).
6. Kowall, N. W., M. F. Beal, J. Busciglio, L. K. Duffy, and B. A. Yankner. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA 88:7247-7251 (1991).
7. Pike, C. J., A. I. Walencewicz, C. G Glabe, and C. W. Cotman. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314 (1991).
8. LaFerla, F., B. T. Tinkle, C. J. Bieberich, C. Haudenschild, and G. Jay. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9:21-30 (1995).
9. Burdick, D., B. Soreghan, M. Kwon, I. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe. Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267: 546-554 (1992).
10. Simmons, L. K., P C. May, K. J. Tomaselli, R. E. Rydel, K. S. Fuson, E. F. Brigham, S. Wright, I. Lieberburg, G. W. Becker, D N. Brems, and W. Y. Li. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol. Pharmacol. 45:373-379 (1994).
11. Koh, J.-Y., I. I. Yang, and C. W. Cotman. β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:315-320 (1990).
12. Mattson, M. P., B. Cheng, D Davis, K. Bryant, I. Lieberburg, and R. E. Rydel. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:379-389 (1992).
13. Behl, C., J. Davis, G. M. Cole, and D. Schubert. Vitamin E protects nerve cells from β amyloid protein toxicity. Biochem. Biophys. Res. Commun. 186:944-950 (1992).
14. Behl, C., J. Davis, R. Lesley, and D. Schubert. Hydrogen peroxide mediates amyloid protein toxicity. Cell 77:817-827 (1994).
15. Butterfield, O. A., K. Hensley, M. Harris, M. Mattson, and J. Carney. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence specific fashion: implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:710-715 (1994).
16. Goodman, Y., and M P. Mattson. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1-12 (1994).
17. Hensley, K., J. M. Carney, M. P. Mattson, M. Aksenova, M. Harris, J. Wu, and D. A. Butterfield. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270-3274 (1994).
18. Schubert, D., C. Behl, R. Lesley, A. Brack, D. Dargusch, Y. Sagara, and H. Kimura. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl. Acad. Sci. USA 92:1989-1993 (1995).
19. Loo, D. T., C Agata, C. J. Pike, E. R. Whittemore, A. J. Wulencewicz, and C. W. Cotman. Apoptosis is induced by β-amyloid in cultured nervous system neurons. Proc. Natl. Acad. Sci. USA 90:7951-7955 (1993).
20. Behl, C., J. Davis, F. G. Klier, and D. Schubert. Amyloid β peptide induces necrosis rather than apoptosis. Brain Res. 645:253-264 (1994).
21. Su, J. H., A. J. Anderson, B. J. Cummings, and C. W. Cotman. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533 (1994).
22. Watt, J. A., C. J. Pike, A. J. Walencewicz-Wasserman, and C. W. Cotman. Ultrastructural analysis of β-amyloid induced apoptosis in cultured hippocampal neurons Brain Res. 661:147-156 (1994).
23. Prehn, J. H. M., B. Peruche, K. Unsicker, and J Krieglstein. Isoform-specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate. J. Neurochem. 60:1665-1672 (1993).
24. Prehn, J. H. M., V P. Bindokas, C. J. Marcuccilli, S. Krajewski, J. C. Reed, and R. J. Miller. Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA 91:12599-12603 (1995).
25. Krajewski, S., S. Tanaka, S Takayama, M. Schibler, W. Fenton, and J. C. Reed. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53:4701-4714 (1993).
26. Krajewski, S., M. Krajewski, A. Shabaik, T. Miyashita, H. G. Wang, and J. C. Reed. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145:1323-1326 (1994).
27. Gottschalk, A. R., L. H. Boise, C. B. Thompson, and J Quintans. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl Acad. Sci. USA 91:7350-7354 (1994).
28. Abele, A. E., K P. Scholz, W. K. Scholz, and R. J. Miller. Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neuron 2:413-419 (1990).
29. 28k Proc. Natl. Acad. Sci. USA 92:5144-5148 (1995).
30. Graham, F. L., J Smiley, W. C. Russel, and R. Nairn. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Genet. Virol. 36:59-72 (1977).
31. Jordan, J , G D. Ghadge, J. H. M. Prehn, P. T. Toth, R. P. Roos, and R. J. Miller. Expression of human Cu/Zn superoxide dismutase inhibits the death of rat sympathetic neurons caused by withdrawal of nerve growth factor. Mol. Pharmacol. 47:1095-1100 (1995).
32. Sherman, L , N. Dagni, J Lieman-Hurwitz, and Y. Croner. Nucleotide sequence and expression of human chromosome nucleotide sequence and expression of human chromosome 21 superoxide dismutase mRNA. Proc. Natl. Acad Sci. USA 80:5465-5469 (1983).
33. Barr, E., J. Carrol, S. Tripathy, K. Kozarsky, J. Wilson, and J. Leiden. Efficient catheter mediated gene transfer into heart using replication defective adenovirus. Gene Ther. 1:51-58 (1994).
34. Bindokas, V. P., J. R. Brorson, and R. J. Miller. Characteristics of voltage sensitive calcium channels in dendrites of cultured rat cerebellar neurons. Neuropharmacology 32:1213-1220 (1993).
35. 2+ dependent changes in the mitochondrial energetics in single dissociated mouse sensory neurons Biochem J. 283:41-50 (1992).
36. Rothe, G., and G. Valet. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J. Leukocyte Biol. 47:440-448 (1992).
37. 36a. Bindokas, V. P., J Jordán, C. L. Lee, and E. J Miller. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J. Neurosci., in press (1996).
38. Fridovich, I. Superoxide radical, an endogenous toxicant. Annu. Rev. Pharmacol. Toxicol. 23:239-257 (1983).
39. Lafon-Cazal, M., S. Petri, M. Culcasi, and J. Bockaert. NMDA-dependent superoxide production and neurotoxicity. Nature (Lond.) 364:535-537 (1993).
40. Kumar, U., D. M. Dunlop, and J. S. Richardson. Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. Life Sci. 54:1855-1860 (1994).
41. Shearman, M S., C. I. Ragan, and L. L. Iversen. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. Natl. Acad. Sci. USA 91:1470-1474 (1994).
42. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6 (1994).
43. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609-619 (1993).
44. Yin, X. M., Z. N. Oltvai, and S. I. Korsmeyer. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature (Lond.) 369:321-323 (1994).
45. Chao, C., C. Hug, F. H. Kravitz, M. Tsang, W. R. Anderson, and P. K. Peterson. Transforming growth factor β protects human neurons against β-amyloid induced injury. Mol. Chem. Neuropathol. 23:159-169 (1994).
46. Lockhart, B P., C. Benicourt, J.-L. Jenien, and A. Prevat. Inhibitors of free radical formation fail to attenuate direct β-amyloid 25-35 peptide mediated neurotoxicity in rat hippocampal cultures. J. Neurosci. Res. 39:494-505 (1994).
47. Bass, D. A., J. W. Parce, L. R. Dechatelet, P. Szejda, M. C. Seeds, and M. Thomas. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol. 130: 1910-1917 (1983).
48. Cathcart, R., E. Schwiers, and B. N. Ames. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal. Chem. 134:111-116 (1983).
49. Zhu, H., G. L. Bannenberg, P. Moldéus, and H. G. Shertzer. Oxidation pathways for the intracellular probe 2′,7′-dichloroflourescein. Arch. Toxicol. 68:582-587 (1994).
50. Harris, M. E., J. M. Carney, P S. Cole, K. Hensley, B J. Howard, L. Martin, P. Bummer, Y. Wang, N. W. Pedigo, Jr., and D. A. Butterfield. β-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport 6:1875-1879 (1995).
51. Arispe, N., E. Rojas, and H. B. Pollard. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA 90:567-571 (1993).
52. Chauhan, A., V. P. S. Chauhan, H Brockerhoff, and H. M. Eisneiwski Effect of amyloid β-protein on membrane properties, in Alzheimer's Disease: Advances in Clinical and Basic Research. (B. Corain, K. Iqbal, M. Nieolini, H. Winbald, H. Wisniewski, and P. Zatta, eds.). John Wiley & Sons, New York, 281-289 (1993).
53. Simmons, M. A., and C. R. Schneider Amyloid peptides act directly on single neurons. Neurosci Lett. 150:133-136 (1993).
54. Brorson, J. R., V P. Bindokas, T Iwama, C. J. Marcuceilli, J. C. Chisholm, and R. J. Miller. The Ca influx induced by β-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. J. Neurobiol. 26:325-339 (1995).
55. Busciglio, J., J Yeh, and B. A. Yankner. β-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61:1565-1568 (1993).
56. 2+ channel blockers attenuate β-amyloid peptide toxicity to cortical neurons in culture. J. Neurochem. 62:372-375 (1994).
57. Davidson, R. M., L. Shajenko, and T. S. Donta. Amyloid beta-peptide (AβP) potentiates a nimodipine-sensitive L-type barium conductance in N1E-115 neuroblastoma cells. Brain Res. 643:324-327 (1994).
58. Baffy, G., T. Miyashita, J. R. Williamson, and J. C. Reed. Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3 dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268:6511-6519 (1993).
59. Richter, C. Pro-oxidants and mitochondrial Ca: their relationship to apoptosis and oncogenesis. FEBS Lett. 325:104-107 (1993).
60. Hof, P. R., E. A. Nimchinsky, M R. Celio, C. Bouras, and J. H. Morrison. Calretinin immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270-3274 (1993).
61. Pike, C. J., and C. W. Cotman. Calretinin immunoreactive neurons are resistant to β-amyloid toxicity in vitro. Brain Res. 671:293-298 (1995).
62. Rossor, M. N., N. J. Garrett, A. L. Johnson, C. Q. Mountjoy, M. Roth, and L. L. Iversen. A postmortem study of the cholinergic and GABA systems in senile dementia. Brain 105:313-330 (1982).
63. Mountjoy, C. Q., M. N. Rossor, L. L. Iversen, and M. Roth. Correlation of cortical cholinergic and GABA defeats with quantitative neuropathological findings in senile dementia. Brain 107:507-518 (1984).
64. Pike, C. J., and C. W. Cotman. Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience 56:269-274 (1993).
65. Wiessner, C., J. Gehrmann, D. Lindhohn, R. Töpper, G. W. Kreutzberg, and K. A. Hossmann. Expression of transforming growth factor β-1 and interleukin-β1 mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol. 86:439-446 (1993).
66. Cribbs, D. H., J. C. Martinou, J. K. Knowels, and C. W. Cotman. β-Amyloid induced neurotoxicity is blocked by overexpression of Bcl-2 in transgenic mice. Soc. Neurosci. Abstr. 20:604 (1994).
67. Boise, L. H., M. Gonzalez-Garcia, C. E. Postema, L. Ding, T. Lindsten, L. A. Turka, X. Mao, G. Nunez, and C. B. Thompson. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608 (1993).
68. Motoyama, N., F. Wang, K. A. Roth, H. Sawa, K. I. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D. Y. Loh. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science (Washington D C.) 267:1506-1510 (1995).
69. Gonzalez-Garcia, M., I. Garcia, L. Y. Ging, S. Oshea, L. H. Boise, C. B. Thompson, and G. Nunez. Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA 92:4304-4308 (1995).
70. Hockenbery, D. M, G. Nunez, C. Milliman, R. D. Schreiber, and S. J Korsmeyer. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.) 348:334-336 (1990).
71. L is the major bcl-x mRNA expressed during murine development and its product localizes to mitochondria. Development 120:3033-3042 (1994).
72. Hennet, T., G. Bertoni, C. Richter, and E. Peterhans. Expression of bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor mediated cytotoxicity. Cancer Res. 53:1456-1460 (1993).
73. Van der Wal, E. A., F. Gomez-Pinilla, and C. W. Cotman. Transforming growth factor β-1 is in plaques in Alzheimer and Down's pathologies Neuroreport 4:69-72 (1993).